A novel human suspension culture packaging cell line for production of high-titre retroviral vectors

Gene Therapy

Volumn 8, Issue 9, 2001, Pages 697-703

  Chan, L M C ^a   Coutelle, C ^a   Themis, M ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

High titre; Producer cell line; Suspension culture

Indexed keywords

BETA GALACTOSIDASE; BUTYRIC ACID;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DENSITY; CELL GROWTH; CELL LINE; CELL NUCLEUS; CELL SUSPENSION; CONTROLLED STUDY; CULTURE MEDIUM; ELECTROPHORESIS; GENE LOCATION; GENE THERAPY; GENETIC CODE; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; SERUM; ULTRAFILTRATION; VIRUS PARTICLE; VIRUS REPLICATION; VIRUS TITRATION;

BETA-GALACTOSIDASE; BLOTTING, WESTERN; BUTYRATES; CELL COUNT; CELL LINE; CULTURE MEDIA, SERUM-FREE; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE THERAPY; GENETIC VECTORS; HUMANS; PLASMIDS; RETROVIRIDAE; TRANSCRIPTION, GENETIC; TRANSDUCTION, GENETIC; ULTRAFILTRATION;

ANIMALIA; RNA VIRUSES; UNIDENTIFIED RETROVIRUS;

EID: 0034982043     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301456     Document Type: Article

References (21)

1. Large-scale processing of recombinant retroviruses for gene therapy
2. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: Concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells
3. Production of increased titer retrovirus vectors from stable producer cell lines by superinfection and concentration
4. Improved retroviral packaging lines derived from spleen necrosis virus
5. Downstream insertion of the adenovirus tripartite leader sequence enhances expression in universal eukaryotic vectors
6. Closed hollow-fiber bioreactor: A new approach to retroviral vector production
7. Proteoglycans secreted by packaging cell lines inhibit retrovirus infection
8. Removal of proteoglycans increases efficiency of retroviral gene transfer
9. Production of retroviral vectors for gene therapy with the human packaging cell line FLYRD18
10. Development of improved adenosine deaminase retroviral vectors
11. Type C retrovirus inactivation by human complement is determined by both the viral genome and the producer cell
12. Retroviral retargeting by envelopes expressing an N-terminal binding domain
13. Improved retroviral vectors for gene transfer and expression
14. Activation of Moloney murine leukemia virus LTR enhances the titer of recombinant retrovirus in psi CRIP packaging cells
15. High-titre packaging cells producing recombinant retroviruses resistant to human serum
16. Isolation and properties of Moloney murine leukemia virus mutants: Use of a rapid assay for release of virion reverse transcriptase
17. Human lymphoblastoid lines from lymph node and spleen
18. Retroviral-mediated gene transfer into hepatocytes in vivo
19. Ping-pong amplification of a retroviral vector achieves high-level gene expression: Human growth hormone production
20. Retroviral end-point titer is not predictive of gene transfer efficiency: Implications for vector production
21. Enhanced in vitro and in vivo gene delivery using cationic agent complexed retrovirus vectors